The Manchester-based company’s funding round will help it develop its device which makes sure that patients take their medicines correctly.
Manchester-based medtech company Pill Connect has received undisclosed funding to continue scaling its reusable device, which attaches to the top of standard-sized pill bottles and provides real-time dispensing data to pharmaceutical companies, including when and how many pills have been dispensed.
The funding round was led by the GMC Life Sciences Fund By Praetura, and through NPIF II – Praetura Equity Finance, which is managed by Praetura Ventures as part of the Northern Powerhouse Investment Fund II.
The Pill Connect device integrates with clinical trial software and the company’s own companion mobile app. It provides patients and those taking part in clinical trials with a dashboard and alerts to manage past and future doses more effectively.
The company’s technology can also help vulnerable people, including dementia sufferers and the elderly, by locking medicine bottles to prevent over-dispensation as well as reminding patients of upcoming doses.
“This fundraise, backed by Praetura and our existing investors, will enable us to expand our team in line with our growing pipeline whilst allowing us to refine our next generation cellular dispenser and explore a wealth of new use case opportunities,” said James Burnstone, chief executive of Pill Connect and inventor of the device.
